
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Companys immune-educating platform: the DPX technology. Through a differentiated mechanism of action, the DPX platform delivers instruction to the immune system to generate a specific, robust, and persistent immune response. IMVs lead candidate, maveropepimut-S (MVP-S), delivers antigenic peptides of survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers. MVP-S treatment has been well tolerated and has demonstrated defined clinical benefit in multiple cancer indications as well as the activation of a targeted and sustained, survivin-specific anti-tumor immune response. MVP-S is currently being evaluated in...
Immunotherapy,dpx platform,oncology,immuno-oncology,cancer,ovarian cancer,dlbcl,bladder cancer,breast cancer,and solid cancer
Imv inc operates in the Biotechnology industry.
Imv inc's revenue is 11m - 100m
Imv inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.